valuation

Shot Tower Capital confirms Hipgnosis valuation amid damning due diligence report

Also concludes HSF held a ‘conflicted position’ when recommending the sale of 29 catalogues to shareholders

March 28, 2024

Search portfolio Adviser

Sponsored by iShares

Ready to rethink your portfolio? Putting cash to work with bond ETFs

About Us
Cookie policy
Privacy policy
Acceptable use policy
Terms and conditions
Contact

LinkedIn

Published by MA Financial Media Ltd (part of Mark Allen),
St Jude’s Church, London SE24 0PB . Copyright (c) 2024.

Portfolio Adviser is a monthly news magazine and daily news web site aimed at wealth managers , investment IFAs and other professional fund pickers and asset allocators in the UK and Channel Islands. No news, articles or content may be reproduced in part or in full without express permission of Portfolio Adviser.

valuation

Shot Tower Capital confirms Hipgnosis valuation amid damning due diligence report

Ready to rethink your portfolio? Putting cash to work with bond ETFs